Dr Amir Enshaei Melvin Joy Ellie Butler Professor Anthony Moorman
| A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study | 2024 |
|
Claire Schwab Dr Ruth Cranston Dr Sarra Ryan Ellie Butler Emily Winterman et al. | Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial | 2023 |
|
Dr Tom Creasey Emilio Barretta Dr Sarra Ryan Ellie Butler Dr Daniel Leongamornlert et al. | Genetic and genomic analysis of acute lymphoblastic leukaemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials | 2022 |
|
Claire Schwab Daniel Murdy Ellie Butler Dr Amir Enshaei Emily Winterman et al. | Genetic characterisation of childhood B-other-acute lymphoblastic leukaemia in UK patients by fluorescence in situ hybridisation and Multiplex Ligation-dependent Probe Amplification | 2022 |
|
Professor Anthony Moorman Emilio Barretta Ellie Butler Eleanor Ward Dr Amir Enshaei et al. | Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study | 2022 |
|
Professor Anthony Moorman Dr Grace Antony Ellie Butler Dr Amir Enshaei Professor Christine Harrison FRCPath FMedSci et al. | Time to Cure for Childhood and Young Adult Acute Lymphoblastic Leukemia Is Independent of Early Risk Factors: Long-Term Follow-Up of the UKALL2003 Trial | 2022 |
|